Legend Biotech Corporation

LEGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.63

+$0.10 (+0.54%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-297.58M	-158.13M	-520.12M	-445.72M	-407.2M	-308.29M
Depreciation & Amortization	28.98M	23.36M	20.45M	18.39M	13.92M	9.93M
Stock-Based Compensation	n/a	68.94M	47.68M	34.34M	20.16M	4.76M
Other Working Capital	-501.32K	-70.57M	90.54M	72.16M	135.39M	26.75M
Other Non-Cash Items	261.49M	-98.24M	130.06M	10.68M	12.82M	93.83M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-93.35M	20.04M	-71.34M	181.03M	161.83M	-23.24M
Operating Cash Flow	-100.47M	-144.03M	-393.28M	-201.28M	-198.47M	-223.01M
Capital Expenditures	-67.58M	-14.11M	-22.72M	-22.28M	-45.4M	-30.28M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-4.55B	-2.71B	-4.86B	-654.97M	-377.96M	-72.68M
Sales Maturities Of Investments	5.33B	1.93B	5.08B	614.86M	230.08M	98.29M
Other Investing Acitivies	n/a	-54.34M	-100.52M	-16.05M	-4.91M	-23.52M
Investing Cash Flow	711.48M	-850.54M	92.79M	-77.09M	-194.98M	-24.17M
Debt Repayment	n/a	-4.02M	-3.76M	-2.6M	-1.42M	-2.6M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.61M	9.72M	795.25M	2.93M	4.64M	-1.05M
Financial Cash Flow	-300.79K	5.7M	791.49M	377.98M	626.66M	618.88M
Net Cash Flow	615.09M	-990.96M	491.68M	97.09M	233.25M	372.33M
Free Cash Flow	-168.04M	-158.14M	-416M	-223.56M	-243.87M	-253.29M
Adj. Free Cash Flow	-168.04M	-227.08M	-463.68M	-257.89M	-264.03M	-258.05M
Maintenance CapEx	n/a	n/a	n/a	n/a	-45.4M	-15.9M
Growth CapEx	-67.58M	-14.11M	-22.72M	-22.28M	n/a	-14.38M
Owner Earnings	-100.47M	-144.03M	-393.28M	-201.28M	-243.87M	-238.91M